• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒相关鼻眶脑毛霉菌病的ROC分期系统

The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.

作者信息

Naik Milind N, Rath Suryasnata

机构信息

Ophthalmic Plastic Surgery Service, L.V. Prasad Eye Institute, Hyderabad, India.

Ophthalmic Plastic Surgery Service, L.V. Prasad Eye Institute, Bhubaneshwar, India.

出版信息

Semin Ophthalmol. 2022 Apr 3;37(3):279-283. doi: 10.1080/08820538.2021.1946094. Epub 2021 Jul 14.

DOI:10.1080/08820538.2021.1946094
PMID:34260342
Abstract

PURPOSE

To report and validate an objective staging system for COVID-related Rhino-Orbito-Cerebral mucormycosis (ROCM).

METHODS

Proof of concept of a new ROC staging system was devised for COVID-related ROCM. The staging system was based on data points drawn from a comprehensive ophthalmic examination, diagnostic endoscopy, and appropriate imaging of orbit, paranasal sinuses and brain in post-COVID ROCM patients to formulate the final staging expressed as ROC. Each stage in the sinus, orbit and brain was graded into three levels of severity of disease. Progressive stages necessitated more active and urgent intervention and poorer prognosis. Finally, ten consecutive ROCM patients were independently staged by two blinded clinicians by examining clinical photographs and radiological images and the results matched for concordance.

RESULTS

Each component of the staging: Rhino, Orbital, and Cerebral were graded 0-3 based on severity. Each stage was matched with a recommended management plan. The final ROC grading by two independent clinicians showed a high degree of concordance - maximum for orbit grade (100%) followed by brain (90%) and sinuses (80%). Overall ROC staging had 70% concordance. Extrapolation of final ROC staging of two clinicians showed 60% match. When we allowed for one-point difference in the ROC staging system the concordance between two clinicians improved to 100% and the management plan matched in 90%.

CONCLUSION

The proposed ROC staging system based on objectively defined clinico-radiological criteria of the three components of COVID-related ROCM is simple-to-use and has high concordance when validated by independent clinicians. The staging helps devise a management plan and has prognostic value.

摘要

目的

报告并验证一种针对新冠相关鼻眶脑毛霉菌病(ROCM)的客观分期系统。

方法

为新冠相关ROCM设计了一种新的RO分期系统的概念验证。该分期系统基于新冠后ROCM患者全面眼科检查、诊断性内镜检查以及眼眶、鼻窦和脑部的适当影像学检查所获取的数据点,以制定最终的RO分期。鼻窦、眼眶和脑部的每个阶段根据疾病严重程度分为三个等级。进展期需要更积极和紧急的干预,且预后较差。最后,两名盲法临床医生通过检查临床照片和放射影像对连续10例ROCM患者进行独立分期,结果进行一致性匹配。

结果

分期的每个组成部分:鼻、眼眶和脑部根据严重程度分为0 - 3级。每个阶段都匹配了推荐的管理计划。两名独立临床医生的最终RO分级显示出高度一致性——眼眶分级的一致性最高(100%),其次是脑部(90%)和鼻窦(80%)。总体RO分期的一致性为70%。两名临床医生最终RO分期的外推显示匹配度为60%。当我们在RO分期系统中允许有一分的差异时,两名临床医生之间的一致性提高到100%,管理计划的匹配度为90%。

结论

所提出的基于新冠相关ROCM三个组成部分客观定义的临床放射学标准的RO分期系统易于使用,经独立临床医生验证后具有高度一致性。该分期有助于制定管理计划并具有预后价值。

相似文献

1
The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.新型冠状病毒相关鼻眶脑毛霉菌病的ROC分期系统
Semin Ophthalmol. 2022 Apr 3;37(3):279-283. doi: 10.1080/08820538.2021.1946094. Epub 2021 Jul 14.
2
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
3
Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.COVID-19 后发生的鼻眶脑毛霉病经皮眶后注射脂质体两性霉素 B 的转归:我们的经验。
Indian J Ophthalmol. 2022 Mar;70(3):1019-1024. doi: 10.4103/ijo.IJO_2356_21.
4
Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.是否意味着毛霉菌病的终结?COVID 相关的鼻-眶-脑毛霉菌病的全面管理:保留可挽救的。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):819-827. doi: 10.1007/s00405-022-07620-3. Epub 2022 Sep 2.
5
COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.COVID-19 相关的鼻眶脑毛霉菌病:系统评价、荟萃分析和荟萃回归分析。
Indian J Pharmacol. 2021 Nov-Dec;53(6):499-510. doi: 10.4103/ijp.ijp_839_21.
6
Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.新冠后 rhino-orbito-cerebral mucormycosis:大流行控制挑战的新挑战。
Eur Arch Otorhinolaryngol. 2022 May;279(5):2417-2422. doi: 10.1007/s00405-021-07010-1. Epub 2021 Jul 26.
7
Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.COVID-19 时代的 ROCM(鼻眶脑毛霉菌病)流行的手术和医学管理及其结果- 一家三级护理中心的经验。
J Mycol Med. 2022 May;32(2):101238. doi: 10.1016/j.mycmed.2021.101238. Epub 2021 Dec 25.
8
Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.COVID-19 后鼻眶脑毛霉菌病(ROCM)的临床特征、治疗及结局:一项多中心研究。
Ophthalmic Plast Reconstr Surg. 2021;37(5):488-495. doi: 10.1097/IOP.0000000000002030.
9
Spectrum of orbital fat necrosis in rhino-orbital-cerebral mucormycosis in post-COVID-19 patients.COVID-19 后患鼻-眶-脑毛霉菌病患者眶内脂肪坏死的范围。
Indian J Ophthalmol. 2024 Oct 1;72(10):1478-1482. doi: 10.4103/IJO.IJO_2623_23. Epub 2024 Sep 27.
10
Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.COVID-19 相关的非糖尿病、免疫功能正常患者的鼻眶脑毛霉菌病。
Orbit. 2021 Dec;40(6):499-504. doi: 10.1080/01676830.2021.1960382. Epub 2021 Aug 1.

引用本文的文献

1
Arora-Nagarkar Prognostic Classification for Rhinocerebral Mucormycosis: A Novel Prognostic Classification System.鼻脑型毛霉菌病的阿罗拉-纳加尔卡尔预后分类:一种新型预后分类系统。
Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):412-416. doi: 10.1007/s12070-024-05210-9. Epub 2024 Nov 15.
2
Utility of intraoperative scoring system in rhino-orbital mucormycosis as a prognostic tool.术中评分系统在鼻眶脑毛霉菌病中的应用作为一种预后工具。
Acta Otorhinolaryngol Ital. 2024 Oct;44(5):313-321. doi: 10.14639/0392-100X-N2705.
3
Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study.
基于一种新的手术分期系统的新冠相关鼻眶脑毛霉菌病全手术清创结果:一项队列研究
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):298-308. doi: 10.1007/s12070-023-04151-z. Epub 2023 Aug 29.
4
Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.COVID-19 大流行期间的鼻-眶-脑毛霉病及其再现:综述。
Indian J Ophthalmol. 2023 Jan;71(1):39-56. doi: 10.4103/ijo.IJO_1219_22.
5
Diagnostic Performance and Clinical Utility of Conventional PCR Assay in Early Diagnosis of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis.常规PCR检测在COVID-19相关鼻-眶-脑毛霉菌病早期诊断中的诊断性能及临床应用价值
J Fungi (Basel). 2022 Aug 11;8(8):844. doi: 10.3390/jof8080844.